Account Executive - MI Clarity - Rocky Midwest

Caris Life Sciences•Remote - Texas, TX

About The Position

The Account Executive – MI Clarity is responsible for driving awareness, adoption, and utilization of MI Clarity, an AI-powered prognostic assay designed to assess early and late distant recurrence risk in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer. The role partners with oncologists, breast surgeons, pathologists, nurse navigators, and healthcare systems to explain the test’s clinical value, integrate it into clinical workflows, and increase appropriate utilization. The position requires knowledge of oncology, breast cancer treatment pathways, molecular diagnostics, and value-based clinical conversations. Success is measured through account engagement, clinician adoption, testing utilization, and long-term strategic growth. Travel within the assigned territory is required, including possible evenings, weekends, or holidays.

Requirements

Bachelor’s degree required.
At least 3 years of successful sales experience in one or more of the following: Oncology, Diagnostics, Molecular Testing, Pathology, Medical Device, or Pharmaceutical sales.
Strong understanding of breast cancer treatment pathways and oncology terminology.
Proven ability to build relationships with healthcare providers and health systems.
Excellent presentation, communication, and consultative selling skills.
Ability to interpret and communicate clinical data.
Ability to travel within the assigned territory.

Nice To Haves

Degree in a life sciences or healthcare-related field.
Experience selling oncology diagnostics or precision medicine solutions.
Existing relationships within oncology or breast centers.
Experience launching new products or assays.
Familiarity with pathology workflows and digital pathology.
Knowledge of prognostic and predictive breast cancer assays.

Responsibilities

Educate healthcare providers and care teams on MI Clarity’s clinical utility, prognostic value, and supporting evidence, including its assessment of early and late distant recurrence risk in eligible breast cancer patients.
Present clinical data, validation studies, and evidence-based insights, and explain how AI-driven pathology analysis differs from traditional genomic and molecular assays.
Conduct in-person and virtual educational programs and lead consultative, evidence-based discussions on risk stratification, treatment planning, extended endocrine therapy considerations, and opportunities to reduce overtreatment and undertreatment.
Position MI Clarity as a clinical decision-support tool and address questions about assay performance, patient selection, workflow integration, turnaround time, and clinical interpretation.
Develop and execute strategic territory and account plans to drive awareness, adoption, and utilization of MI Clarity.
Build and maintain relationships with medical oncologists, breast surgeons, pathologists, advanced practice providers, nurse navigators, health system administrators, and other clinical decision-makers.
Identify and engage key opinion leaders, decision-makers, and clinical champions within target accounts to support adoption and long-term utilization.
Support implementation of testing workflows and operational integration within healthcare systems and clinical practices.
Analyze territory and account performance data to identify growth opportunities, monitor utilization and adoption trends, and develop targeted engagement strategies.
Maintain accurate CRM documentation, forecasting, and account activity records.
Collaborate with Medical Affairs, Marketing, Operations, Customer Support, and other internal teams to support customer success and business objectives.
Conduct activities in compliance with company policies, healthcare regulations, and industry standards, maintaining accurate, balanced, and approved clinical and promotional communications.